Helvetica Chimica Acta Vol.85 (2002)
263
anh.THF under Ar.The soln.was stirred at r.t.for 16 h.The solvent was removed
in vacuo, and the residue was
taken up in 20 ml of FC-72.The fluorous phase was washed with aq.citric acid solns.(10%) (2 Â 5 ml), dried
over Na2SO4, and concentrated in vacuo.
(4-{Tris[2-(perfluorohexyl)ethyl]silyl}benzyl) 2-{[(Furfuryl)amino]carbonyl}phenylcarbamate (14a):
160 mg (87%). 1H-NMR (400 MHz, FC-72/C6D6-capillary): 1.28 1.42 (m, 3 CH2Si); 2.21 2.39 (m, 3 CH2CF2);
4.55 (s, NCH2); 5.21 (s, PhCH2); 6.29 (d, J 1.5, 1 arom. H (furan)); 6.31 (d, J 1.5, 1 arom. H (furan)); 6.79
(t, J 5.0, NH); 7.25 (t, J 5.0, 1 arom. H); 7.32 (s, 1 arom.H (furan)); 74. 0 ( d, J 7.0, 1 arom. H); 7.51 (d, J
7.5, 2 arom. H); 7.60 (d, J 7.5, 2 arom. H); 7.72 (m, 1 arom.H); 83. 4 ( d, J 6.5, 1 arom. H); 10.88 (s, NH).CI-
MS (2208, 50 eV): 1419 (13, M ), 1158 (53), 399 (7), 243 (100), 147 (14).
(4-{Tris[2-(perfluorohexyl)ethyl]silyl}benzyl) 4-Chloro-2-{[(furfuryl)amino]carbonyl}phenylcarbamate
(14b): 175 mg (82%). 1H-NMR (400 MHz, FC-72/C6D6-capillary): 1.31 1.40 (m, 3 CH2Si); 2.21 2.41
(m, 3 CH2CF2); 4.60 (s, NCH2); 5.25 (s, PhCH2); 6.34 (d, J 1.5, 2 arom. H (furan)); 6.82 (d, J 4.5, NH);
7.35 ( m, 2 arom. H); 7.55 (d, J 7.5, 2 arom. H); 7.64 (d, J 7.5, 2 arom. H); 7.80 (m, 1 arom.H); 8.38
(s, 1 arom.H); 109. 5 ( s, NH).EI-MS (230 8, 70 eV): 1452 (4, M ), 1175 (10), 1159 (34), 399 (41), 175 (51),
96 (100).
General Procedure for the Cyclization of the Amides 14a,b to the Quinazoline-2,4-diones 15a,b.To a soln.of
0.1 mmol of 14a,b in 10 ml of DMF, 0.2 ml (0.14 mg, 1.0 mmol) of Et3N were added.The cloudy mixture was
heated in a vial with a screw cap to 1108 for 16 h.After cooling to rt.,. the vial was carefully opened, and the
contents were poured into 50 ml of H2O.The aq.phase was extracted with FC-72 (2 Â 10 ml) and with AcOEt
(2 Â 10 ml).The org.phase 6) was washed with 0.5m solns.of aq.HCl (2 Â 5 ml), dried over Na2SO4, and
concentrated in vacuo to yield the quinazoline-2,4-diones as colorless crystalline powders.
3-Furfurylquinazoline-2,4-dione (15a): 16 mg (66%).Mp. .245 8. 1H-NMR (400 MHz, (CD3)2SO): 5.06 (s,
PhCH2); 6.29 (d, J 2.6, 1 arom. H (furan)); 6.38 (t, J 2.5, 1 arom. H (furan)); 7.20 (m, 2 arom.H); 75. 2
(s, 1 arom.H (furan)); 76. 5 ( t, J 7.8, 1 arom. H); 7.93 (d, J 8.0, 1 arom. H); 11.00 (s, NH). 13C-NMR
(100 MHz, (CD3)2SO): 36.1 (NCH2); 108.1 (arom. C); 109.8 (arom. C); 113.6 (arom. C); 114.9 134.3
(4 arom. C); 139.0 (arom. C); 141.2 (arom. C); 149.9 (arom. C); 150.0 (CO); 161.7 (CO).EI-MS (230 8,
70 eV): 242 (100, M ), 213 (16), 146 (22), 81 (45).Anal.calc.for C 13H10N2O3 (242.07): C 64.46, H 4.16, N 11.56;
found: C 64.33, H 4.10, N 11.52.
7-Chloro-3-furfurylquinazoline-2,4-dione (15b): 24 mg (90%).Mp. .256 8. 1H-NMR (500 MHz, (CD3)2SO):
5.06 (s, PhCH2); 6.30 (d, J 2.6, 1 arom. H (furan)); 6.37 (t, J 2.5, 1 arom. H (furan)); 7.20 (s, 1 arom.H); 72. 5
(d, J 7.8, 1 arom. H); 7.54 (s, 1 arom.H (furan)); 79. 3 ( d, J 8.0, 1 arom. H); 11.60 (s, NH). 13C-NMR
(100 MHz, (CD3)2SO): 36.6 (NCH2); 108.0 (arom. C); 110.5 (arom. C); 112.6 (arom. C); 114.6 139.5
(4 arom. C); 140.5 (arom. C); 142.1 (arom. C); 149.6 (arom. C); 150.1 (CO); 160.8 (CO).EI-MS (230 8,
70 eV): 276 (100, M ), 247 (13), 180 (36), 129 (76), 81 (91).Anal.calc.for C 13H9ClN2O3 (276.03): C 56.43,
H 3.28, N 10.13; found: C 55.98, H 3.02, N 9.83. FC-72 phase: 105 mg.
REFERENCES
[1] −Combinatorial Chemistry: A practical approach×, Eds.W.Bannwarth, E.Felder, Wiley-VCH, Weinheim,
2000.
[2] K.A.Newlander, B.Chenera, D.F.Veber, N.C.F.Yim, M.L.Moore,
J. Org. Chem. 1997, 62, 6726; N.D.
Tetrahedron Lett. 1998, 39, 897.
Hone, S.G.Davies, N.J.Devereux, S.L.Taylor, A.D.Baxter,
[3] A.Akelah, D.C.Sherrington,
Chem. Rev. 1981, 81, 557; S.J. Shuttleworth, S.M. Allin, P.K. Sharma,
Synthesis 1997, 1217; S.W.Kaldor, M.G.Siegel, Curr. Opin. Chem. Biol. 1997, 1, 101.
[4] −Chemical Synthesis in Supercritical Fluids×, Eds.P.G.Jessop, W.Leitner, Wiley-VCH, NY. .1999; P.G.
Jessop, T.Ikariaya, R.Noyori, Chem. Rev. 1999, 99, 475; J.A.Darr, M.Poliakoff, Chem. Rev. 1999, 99, 495.
[5] T.Welton, Chem. Rev. 1999, 99, 2071.
¬
¬
[6] I.T.Horva th, J.Ra bai, Science 1994, 266, 55; R.H.Fish, Chem. Eur. J. 1999, 5, 1677; B.Cornils, Angew.
Chem. 1997, 109, 2147; I.T.Horvath, Acc. Chem. Res. 1998, 31, 641; D.P.Curran, Z.R.Lee, Green Chem.
2001, G3 G7.
[7] A.L.Smith, C.G.Thomson, P.D.Leeson,
Bioorg. Med. Chem. Lett. 1996, 6, 1483; L.Gouilleux, J-.A.
Fehrentz, F.Winternitz, J.Martinez, Tetrahedron Lett. 1996, 37, 7031.
6
)
The fluorous phase contained no cyclic products but some unreacted 14a (ca.25%) or 14b (traces) together
with compound 6.